Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024

摘要

This report describes effectiveness of nirsevimab against respiratory syncytial virus-associated hospitalizations in infants.

This report describes effectiveness of nirsevimab against respiratory syncytial virus-associated hospitalizations in infants.

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

萃取時間: 2026-02-05T15:10:06Z 資料來源: CDC MMWR